Across TCGA pan-cancer cohorts, SNORA71A RNA differs between tumor and matched normal tissue in 13 of 18 cancer types tested, making tumor–normal expression one of SNORA71A’s most consistent transcriptional readouts.
The strongest signal is observed in colon adenocarcinoma (COAD), where SNORA71A RNA is more highly expressed in tumor relative to normal tissue. In most cancer types SNORA71A is over-expressed in tumor, although a few such as THCA show the opposite, repressed pattern.
COAD, LUSC, and STAD are the cancer types where SNORA71A tumor–normal differential expression is most reproducible.
RNA tumor vs normal associations by lineage
Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in SNORA71A RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.